Modernization of pharmaceutical education in Kazakhstan: challenges, strategies, and prospects

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.70413/ejar-v05-i10-s6305
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In his Address, President of the Republic of Kazakhstan Kassym-Jomart Tokayev outlined the goal of developing the pharmaceutical industry and expanding domestic drug production by 30%. New pharmaceutical enterprises are being established in the country, international quality standards are being implemented (ISO – International Organization for Standardization, GMP – Good Manufacturing Practice, GDP – Good Distribution Practice, GPP – Good Pharmacy Practice, GCP – Good Clinical Practice), along with drug labeling systems. These changes require the modernization of pharmaceutical education and the training of a new generation of specialists